| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr9_0073800 | Intergenic-Intergenic | chr9:113708110-113708419 | chr9:110945830-110946139 | 310 nt | 0.3871 |
| hsa_LPAR1_0003600 | Intron-Intron | chr9:113715142-113715394 | chr9:110952862-110953114 | 253 nt | 0.5889 |
| hsa_chr9_0073900 | Intergenic-Intergenic | chr9:113721623-113722291 | chr9:110959343-110960011 | 669 nt | 0.4275 |
| hsa_LPAR1_0003700 | Intron-Exon-Intron | chr9:113721773-113798481 | chr9:110959493-111036201 | 80 nt | 0.5375 |
| hsa_LPAR1_0003800 | Intron-Exon-Intron | chr9:113726218-113735838 | chr9:110963938-110973558 | 58 nt | 0.3448 |
| hsa_LPAR1_0004600 | Exon-Exon | chr9:113734353-113735817 | chr9:110972073-110973537 | 57 nt | 0.5263 |
| hsa_LPAR1_0004700 | Intron-Exon-Intron | chr9:113734353-113735860 | chr9:110972073-110973580 | 100 nt | 0.4700 |
| hsa_LPAR1_0004800 | Intron-Exon-Intron | chr9:113734353-113741039 | chr9:110972073-110978759 | 374 nt | 0.4679 |
| hsa_LPAR1_0004900 | Intron-Exon-Intron | chr9:113734353-113746804 | chr9:110972073-110984524 | 148 nt | 0.4932 |
| hsa_LPAR1_0004500 | Intron-Exon-Intron | chr9:113734353-113794360 | chr9:110972073-111032080 | 250 nt | 0.4040 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].